Cargando…
Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells
The proteasome inhibitor bortezomib is an effective anti-cancer agent for the plasma cell malignancy multiple myeloma but clinical response is hindered by the emergence of drug resistance through unknown mechanisms. Drug sensitive myeloma cells were exposed to bortezomib to generate drug resistant c...
Autores principales: | Jaganathan, Sajjeev, Malek, Ehsan, Vallabhapurapu, Subrahmanya, Vallabhapurapu, Sivakumar, Driscoll, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323002/ https://www.ncbi.nlm.nih.gov/pubmed/25481044 |
Ejemplares similares
-
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
por: Jagannathan, S, et al.
Publicado: (2015) -
Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma
por: Potluri, Veena, et al.
Publicado: (2013) -
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
por: Sulaiman, Mahaboob K, et al.
Publicado: (2015) -
Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma
por: Abdel Malek, Mohamed A.Y., et al.
Publicado: (2014) -
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium
por: Vallabhapurapu, Subrahmanya D., et al.
Publicado: (2015)